LEAP-008: pembrolizumab plus lenvatinib after immunotherapy in non-small cell lung cancer.

ABSTRACT:

SUBMITTER: Fukuda K 

PROVIDER: S-EPMC12780427 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature